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Optic vesiclehomeobox-containing transcription factors are expressed in the presumptive eye
ﬁeld and required to initiate eye development. How these factors interact together at the genetic andmolecular
level to coordinate this developmental process is poorly understood. We found that the Lhx2 and Pax6
transcription factors operate in a concerted manner during retinal development to promote transcriptional
activation of the Six6 homeobox-gene in primitive and mature retinal progenitors. Lhx2 demarcates the
presumptive retina ﬁeld at the neural plate stage and Lhx2 inactivation delays initiation of Rx, Six3 and Pax6
expression in this domain. The later expressed Six6 is properly activated in the pituitary/hypothalamic axis of
Lhx2−/− embryos, but expression fails to be initiated in the optic vesicle. Lhx2 and Pax6 associate with the
chromatin at several regions of Six6 in vivo and cooperate for trans-activation of Six6 regulatory elements in
vitro. In retinal progenitor/stem cells, both Lhx2 and Pax6 are genetically required for proper Six6 expression
and forced co-expression of Lhx2 and Pax6 can synergistically trans-activate the Six6 locus. Our work reveals
how twomaster regulators of eye development coordinate their action to sequentially promote tissue-speciﬁc
transcriptional initiation and full activation of a retinal determinant gene.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe optic vesicle of vertebrates originates from the neural tube and
is ﬁrst detected between embryonic stages (e) 8.25 and e8.5 as a
bilateral evagination of the anterior neural plate, named the optic
sulcus (Marquardt, 2003; Oliver and Gruss, 1997). Around e9.5, the
intimate contact between the optic vesicle and the eye surface
ectoderm induces the transformation of the ectoderm into a lens
placode, which is revealed by the proliferation and thickening of the
ectoderm (Oliver and Gruss, 1997). In turn, the lens placode induces
the evagination of the optic vesicle into an optic cup around e10.0. The
optic cup ultimately gives rise to the fully mature neural retina. How
retinal speciﬁcation is established at the neural plate stage and how
deﬁnitive retinal identity is promoted and maintained in retinal
progenitors remain important issues in developmental biology. The
homeobox-containing transcription factors Pax6, Rx, Six3 and Lhx2
are genetically required for eye formation and over-expression of
Pax6, Rx or Six3/Six6 can induce ectopic retinal tissues in frog and ﬁsh
embryos (Bernier et al., 2000; Carl et al., 2002; Chow et al., 1999; Hill
et al., 1991; Loosli et al., 1999; Mathers et al., 1997; Porter et al., 1997;ratory, Maisonneuve-Rosemont
H1T 2M4. Fax: +1514 252 3569.
rnier).
l rights reserved.Zuber et al., 1999). Although the genetic function of these factors has
been highly studied, the molecular mechanisms by which they
coordinate retinal development and establish deﬁnitive retinal
identity remain poorly understood.
Pax6 is a member of the paired-box and homeobox-containing
gene family (PAX) of transcription factors and has been used as a
prototype to study eye development in several model organisms
(Gehring and Kazuho,1999; Gehring, 2002). In mice, Pax6 is expressed
starting at e8.0 in the eye surface ectoderm, and in the eye neural
ectoderm, which gives rise to the optic vesicle (Walther and Gruss,
1991). Despite being anophthalmic at later stage of development,
Pax6-null embryos form an optic vesicle that arrests in development
prior to the optic cup stage (Grindley et al., 1995; Hogan et al., 1986). In
the optic vesicle of Pax6 mutants, neuroepithelial (NE) progenitors
over-proliferate and display an abnormal cell cycle kinetic, possibly
owing to downregulation of cyclin-dependent kinase inhibitors
(Duparc et al., 2007). Conditional mutagenesis of Pax6 in the e11.0
distal retina revealed that Pax6 is required at the time of retinogenesis
to maintain progenitor cells proliferation and generate retinal cell
types diversity, in part through transcriptional activation of pro-neural
genes (Marquardt et al., 2001). Although Pax6 is being considered to
operate at the apex of the genetic cascade governing eye and retinal
development, expression of Lhx2, Rx, Otx2, Six3 and Six6 in the optic
vesicle of Pax6 mutants is unaffected, revealing that early retinal
speciﬁcation does occur in the absence of Pax6 (Bernier et al., 2001;
Jean et al., 1999).
542 N. Tétreault et al. / Developmental Biology 327 (2009) 541–550Lhx2 is a transcription factor that plays an essential role in
mammalian's eye development and that is conserved in lower
vertebrate species (Porter et al., 1997; Zuber et al., 2003). Lhx2
encodes a member of the LIM homeobox-containing transcription
factors family (LHX). LHX proteins can activate or repress gene
transcription by direct DNA binding and associationwith co-activators
or co-repressors through their LIM domain (Agulnick et al., 1996). In
mice, Lhx2 is required for the development of numerous organs,
including the eye, the telencephalon and blood system (Porter et al.,
1997). While little is known about how Lhx2 operates, experiments
have showed that red blood cell defects in Lhx2-null mice are non-cell
autonomous and mediated by abnormalities that lie within the liver
(Porter et al., 1997). In contrast, most abnormalities present in the CNS
appear to be cell autonomous, as revealed by chimera aggregation
studies (Porter et al., 1997). Lhx2 is also expressed by immature B and
T lymphocytes, but not by hematopoietic stem cells (Wu et al., 1996).
Notably, some chromosomal translocations involved in human
leukemia's appear to include the LHX2 locus, and Lhx2 over-
expression can immortalized human hematopoietic stem cells (Wu
et al., 1996). Recent genetic studies have also revealed that Lhx2 is
required for the self-renewal of epithelial stem cells, but the under-
lying molecular mechanism remains elusive (Rhee et al., 2006).
Herein we report on the characterization of Lhx2 function during
the earliest steps of retinal development. We found that Lhx2
represents the ﬁrst retinal determinant gene with Rx within the
presumptive retina ﬁeld, and that Lhx2 mutation results in delayed
induction of Six3, Rx and Pax6 expression in this domain. Later on,
Lhx2 is also required for Six6 expression initiation in the optic vesicle.
In retinal tissue, Lhx2 and Pax6 proteins are bound to the chromatin at
the Six6 locus, and can cooperate to trans-activate Six6 regulatory
elements in vitro. In retinal progenitor/stem cells, Lhx2 and Pax6 are
genetically required for Six6 expression and can cooperate to
synergistically trans-activate the Six6 gene. Our work reveals that
Lhx2 is required to establish primitive retinal identity at the neural
plate stage by allowing initiation of retinal-determinant genes
expression, and how later Lhx2 cooperates with Pax6 to establish
deﬁnitive retinal identity and promote cellular proliferation.
Materials and methods
Animals
Adult mice from the albinos CD1 or 129sv strains were purchased
from Charles River (St-Constant, Qc., Canada). Pax6mutant mice are a
gift from Peter Gruss (Max-Planck Institute, Goettingen) and Lhx2
mutant mice from Heiner Westphal (National Institute of Health,
Bethesda). Embryos stage was determined according to the time of
vaginal plug.
In situ hybridization
Embryos were dissected in PBS, ﬁxed overnight in 4% paraformal-
dehyde at 4 °C and embedded in Paraplast (Monoject Scientiﬁc).
Sections (10 μm) were cut and dried onto super-frost glass slides
(Fisher Scientiﬁc). 35S-labelled RNA probes using SP6, T3 or T7 RNA
polymerase were done with Boehringer enzyme according to the
directive of the company. Exposure time for the radioactive RNA in situ
hybridization was 15 days. For in situ hybridizations on whole
embryos, preparations were hybridized with digoxigenin-labelled
RNA probes and visualized with alkaline phosphatase-coupled anti-
digoxigenin antibody (1/2000) (Boehringer) and NBT/BCIP substrate
(Boehringer) at pH 9.5. For cryosection, embryos were cryoprotected
in 30% sucrose/PBS overnight at 4 °C, embedded in cryomatrix
solution and snap-frozen in liquid nitrogen. Specimens were cut using
a cryostat (Leica) at 10 μm and used for non-radioactive in situ
hybridization.RT-PCR and quantitative real-time PCR
All primers were designed to ﬂank individual exons and tested by
PCR in RT+ and RT− control extracts. Total RNA was isolated using
TRIzol reagent (Invitrogen). Reverse transcription (RT) was performed
using 1 μg of total RNA and the MML-V reverse transcriptase
(Invitrogen). PCR ampliﬁcation was performed using the HotStar
TAQ polymerase (Invitrogen). PCR was run as follow; 94 °C for 10 min,
followed by 30 cycles of denaturing at 94 °C, annealing at 57 °C and
extension at 72 °C in an Applied Biosystems thermal cycler. Real-time
PCR was performed using the Platinum SYBRGreen SuperMix
(Invitrogen) and a Real-Time PCR apparatus (BioRad).
Chromatin immunoprecipitation
ChIP was performed using the ChIP Assay kit (Upstate) according
to the manufacturer's instructions. Brieﬂy, 0.5×106 cells were
sonicated to shear the chromatin. Chromatin-associated proteins
were precipitated using goat anti-Lhx2 (Santa Cruz), rabbit anti-
Pax6 (US Biological) or rabbit anti-IgG (Upstate) antibodies. Samples
were heated to reverse the protein–DNA crosslinks and the DNA
recovered by phenol/chloroform/isoamyl alcohol extraction. Geno-
mic DNA was used as template for PCR ampliﬁcation using primers
to the Six6 loci.
Luciferase assay
Four distinct genomic DNA fragments from the Six6 locus (−3964
to −2465, −2480 to −1263, −1284 to −75 and +638 to +1703) were
cloned into the pGL3 Luciferase Reporter Vector (Promega). Pax6,
Lhx2, Six3 and Otx2 cDNAs were cloned into the expression vector
pCS2+. Reporter vectors were transfected with either one expression
vector or a combination using Lipofectamine 2000 (Invitrogen). 48 h
post-transfection, cells were lysed using Passive Lysis Buffer (Pro-
mega). Cells lysates were analyzed using the Dual Glow Luciferase
Assay System (Promega).
Cell culture
Optic vesicles of e9.5 embryos were dissected-out with tungsten
needles in HBSS, as described (Duparc et al., 2007). Optic vesicles were
directly triturated in HBSS using needles (20G-10x; 22G-5x), in order
to obtain a suspension of single cells. After centrifugation, cells were
placed in neural stem cell (NSC) media: DMEM/F12 (Invitrogen)
containing 0.25% glucose, B27 supplement, Heparin (2 μg/ml; SIGMA),
Gentamycin (25 μg/ml; Invitrogen) and human recombinant FGF2
(10 ng/ml; Preprotech). Cells were cultured in 6 well plates (Sarstedt)
for 3 to 10 days at 37 °C in 5% CO2 atmosphere. When applicable, BrdU
(SIGMA) was added to the culture media at 10 μg/ml. For passage,
single retinal spheres were dissociated with an enzyme-free solution
(CHEMICON). After trituration, the single cell suspension was
harvested at 300 g for 5 min and washed twice with HBSS. Cells
were plated at 2000 cells/ml in neural stem cell media. Cell viability
was evaluated using a hemacytometer and trypan blue exclusion
staining.
Immunoﬂuorescence and immunohistochemistry
For BrdU-labeling experiments, retinal spheres were directly
frozen in liquid nitrogen and post-ﬁxed after sectioning using 100%
ETOH for 30 min and 4% PFA/PBS for 10 min. Sections or cells were
treated with DNase I/0.05% HCl for 30 min in order to reveal BrdU
epitopes. Samples were blocked in 1% BSA (Vector laboratories)/0.1%
Tween 20/PBS solution and incubated with the primary antibodies
overnight at 4 °C. After washes with PBS, samples were incubated
with appropriate secondary antibodies for 1 h at RT. Antibodies
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(Abcam). For immunohistochemistry labeling, 4% PFA/PBS ﬁxed
retinal spheres were equilibrated in sucrose and embed in OCT
compound. Frozen sections were analyzed by using the Vectastain®
ABC kit (Vector) according to the manufacturer instructions.
Peroxidase substrates used is the Vector® DAB (Sigma). Observations
were made under microscope (Leica DMRE, Leica Microsystems) and
images were captured with a digital camera (Retiga EX; QIMAGING;
with OpenLab, ver.3.1.1 software; Open-Lab, Canada). Primary anti-
body used is the rabbit anti-cleaved caspase-3 (Cell signaling).
DNA micro-array
Total RNA was prepared using TRIzol reagent (Invitrogen) and
puriﬁed by the RNeasy MiniElute Cleanup kit (Qiagen) from 6WT and
6 Lhx2−/− e9.0 embryos or 3WT and 3 Pax6−/− retinal stem cell cultures
at passage 2. Microarray analysis using BeadChip Mouse Genome
(Illumina) or GeneChip Mouse Expression Set 430 array, which
contains ∼39,000 transcripts (Afﬁmetrix) was performed at the
Centre d'innovation at Genome Quebec (McGill university, Montreal,
PQ). Data were analyzed using the FlexArray software.
DNA electroporation
Mouse Pax6 and Lhx2 cDNAs were cloned into the EF1α-CMV/GFP
lentiviral vector (L. Cheng, Johns Hopkins University). Retinal stem
cells were nucleofected with plasmids DNA using the Mouse Neural
Stem Cell Nucleofector Kit according to manufacturer's instructions
(Amaxa Biosystems), plated on matrigel (BD Bioscience) in NSC media
for 36 h and sorted for GFP expression by ﬂuorescence activated cell
sorting.
Virus
Mouse Six6 cDNA (Jean et al., 1999) was cloned into EF.V.CMV.GFP
(L. Cheng, Johns Hopkins University) and transfected in 293Tcells with
helper vectors (F. Boudreau, Sherbrooke University) using Lipofecta-
mine 2000 (Invitrogen). Viral supernatants were ultra-centrifuged
and exposed to single cell suspensions O/N. Aggregates wereFig. 1. Lhx2 is expressed in the visual system and demarcates the retina ﬁeld (A–G). (A–C) Wh
neural plate of mouse embryos at the 2 somites stage (A), in the optic vesicle (arrowheads), t
limb bud at e12.5 (C). (D–F) On embryos sections, robust Lhx2 expression was detected in t
central neural retina (nr) and ciliary marginal zone of the retina (cm) at e13.5 and e17.5. No ex
(ls). Non-speciﬁc background signal is observed in the ocular mesenchyme in panel D. (G) I
anterior neural plate corresponding to the presumptive retina ﬁeld, where Six3 and Pax6 ardissociated to single cells and plated at 2000 cells/ml in NSC media
for 1 week. GFP positive retinal spheres were visualized using a
ﬂuorescence-mounted inverted microscope (LEICA).
Statistical analysis
Statistical differences were analyzed using Student's t-test for
unpaired samples. An analysis of variance (ANOVA) followed by the
Dunnett test was used for multiple comparisons with one control
group. In all cases, the criterion for signiﬁcance (P value) was set as
mentioned in the respective ﬁgures.
Results
Lhx2 demarcates the presumptive retina ﬁeld
To characterize Lhx2 expression pattern during mouse eye
development, we performed in situ hybridizations on whole
embryos (WISH). Lhx2 expression was ﬁrst detected in the anterior
neural plate at the 2 somites stage in the region corresponding to
the prospective retina ﬁeld (Fig. 1A) (Furukawa et al., 1997; Mathers
et al., 1997; Zuber et al., 2003). From e9.5 to e12.5, robust Lhx2
expression was observed in the optic vesicle and eye, prospective
telencephalon, and limb bud (Figs. 1B and C). On embryo sections,
Lhx2 expression was detected at e10.5 in all components of the
eye neuroectoderm i.e. optic stalk, optic cup and retinal-pigment
epithelium (RPE), and in the ventral diencephalon (Fig. 1D). In the
e12.5 and e17.5 retina, Lhx2 expression is most intense at the retinal
ciliary margin and distal RPE, with strong expression also in the
outer neural retina and RPE (Figs. 1E and F). Notably, comparative
expression analysis at e8.25 revealed that Lhx2 is co-expressed with
Rx in the anterior neural plate and that Lhx2 overlap-with and is
contained within Rx expression domain (Fig. 1G). In contrast, Six3
expression is predominant in the prospective pituitary/hypothalamic
axis and ventral forebrain, and nearly absent from the retina ﬁeld
(Fig. 1G) (Oliver et al., 1995). Pax6 has a broader and more diffuse
expression throughout the presumptive eye domain, consistent with
its later expression in both epithelial and neuroepithelial derivatives
(Fig. 1G) (Walther and Gruss, 1991).ole-mount in situ hybridization shows that Lhx2 expression is detectable in the anterior
elencephalic vesicle and limb from e9.0 (B), and in the eye (arrowheads), neocortex and
he optic cup (oc) and optic stalk (os) at e10.5, in the retinal-pigment epithelium (rpe),
pressionwas detectable in ectodermal derivatives such as the lens placode (lp) and lens
n 2 somites stage embryos, Lhx2 and Rx expression demarcates a speciﬁc region of the
e not yet expressed (arrowheads).
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retina ﬁeld
Eye development in Lhx2 mutant embryos arrest at the optic
vesicle stage around e9.0, allowing gene expression analysis at this
stage and earlier. To better understand Lhx2 function in eye
development, we performed comparative DNA micro-array analysis
on e9.0 WT and Lhx2−/− forebrains. These experiments revealed that
several genes involved in eye/retinal development are downregu-
lated in Lhx2−/− forebrains, including Mitf, Chx10, Vax2, Rx (Rax),
Tbx5, Fzd5 and Six6 (Table 1). In sharp contrast, the Pax6 mutation
is not associated with a downregulation of Lhx2, Rx, Six3, Chx10,Table 1





NM_011445.1 Sox6 SRY-box containing gene 6 −0,9082
NM_011384.2 Six6 Sine oculis-related homeobox 6
homolog
−0,9108
NM_001085495 Arfgef2 ADP-ribosylation factor guanine
nucleotide-exchange
−0,9412
NM_178192.1 Hist1h4a Histone 1, H4a −0,9438
AK084437 D230046H12Rik Unknown (Riken) −0,9641
NM_013603.1 Mt3 Metallothionein −0,9667
NM_029768.2 Use1 Unconventional SNARE in the ER 1
homolog
−0,9724
AK018697 Ldlr Low density lipoprotein receptor −0,9785
NM_011921 Aldh1a7 Aldehyde dehydrogenase family 1,
subfamily A7
−0,9854
AK013968 3110001N23Rik Unknown (Riken) −0,9872
9530086O07Rik Unknown (Riken) −1,0055
NM_176841.2 Ccdc88a Coiled coil domain containing 88A −1,0313
NM_001033193.1 Fzd5 Frizzled homolog 5 −1,0448
NM_007740.2 Col9a1 Procollagen, type IX, alpha 1 −1,0536
NM_175657 Hist1h4m Histone 1, H4m −1,0674
NM_199065 Slitrk1 SLIT and NTRK-like family, member 1 −1,0994
AK050619 P38ip-pending Transcription factor
(p38 interacting protein)
−1,1068
B830012L14Rik Unknown (Riken) −1,1287
AK084485 D330006D04Rik Unknown (Riken) −1,1665
NM_009719.4 Neurog3 Neurogenin 3 −1,2109
AK032066 Osp94 Osmotic stress protein 94 kDa −1,2355
NM_024226 Rtn4 Reticulon 4, transcript variant 5 −1,2406
AK054516 E330035H20Rik Unknown (Riken) −1,2491
NM_153551.1 Dennd1c DENN/MADD domain containing 1C −1,3124
NM_011537 Tbx5 T-box 5 −1,3659
AK084692 Stk18 Serine/threonine kinase 18 −1,3736
NM_008469.1 Krt1-15 Keratin complex 1, acidic, gene 15 −1,4316
AK013410 Rab14 RAB14, member RAS oncogene family −1,4464
NM_145463 Shisa2 Shisa homolog 2 −1,4861
C230053D17Rik Unknown (Riken) −1,4912
AK054453 E330027G05Rik Unknown (Riken) −1,5453
AK084661 D330026I07Rik Unknown (Riken) −1,5460
NM_013833 Rax Retina and anterior neural fold
homeobox
−1,6921
NM_011912.1 Vax2 Ventral anterior homeobox
containing gene 2
−1,7093
NM_001083587 Tsn3 Tensin 3 −1,7541
AK042261 Sh3pxd2b SH3 and PX domains 2B −1,9207
NM_013467 Aldh1a1 Aldehyde dehydrogenase family 1,
subfamily A1
−1,9287
NM_007701.2 Chx10 C. elegans ceh-10 homolog −1,9390
NM_010024.1 Dct Dopachrome tautomerase −2,0174
NM_001009950 Slc38a8 Solute carrier family 38, member 8 −2,0912




XM_122498.1 Tm7sf1 Transmembrane 7 superfamily
member 1
−2,6245
NM_010024 Dct Dopachrome tautomerase −3,2626
Six forebrains from each genotypes at e9.0 were analyzed using Illumina BeadArray™
technology. Genes in bold have been involved in eye development and are
downregulated in Lhx2−/− embryos.
Fig. 2. Lhx2 is required for Six3, Rx and Pax6 expression in the retina ﬁeld, as
revealed by in situ hybridization (A–D). (A and B) In Lhx2−/− embryos, Six3 expression
is detected in the pituitary/hypothalamic axis and ventral forebrain, but not in the
retina ﬁeld (arrowheads) at neural plate (A) and neural fold (B) stages. (C and D) In
Lhx2−/− embryos, Rx and Pax6 expression is absent or highly reduced in the retina
ﬁeld (arrowheads).Otx2 and Six6 expression in the forebrain and optic vesicle (Bernier
et al., 2001; Duparc et al., 2006; Jean et al., 1999).
Based on the above result, we hypothesized that Lhx2 may
control the expression of eye genes at the earliest steps of retinal
speciﬁcation. To test this, we performed WISH on e8.25/e8.5 WT
and Lhx2−/− embryos, thus prior to any visible morphological
abnormalities in Lhx2 mutants. In e8.25 WT embryos, Six3
expression was robust in the presumptive pituitary/hypothalamic
axis and ventral forebrain region, but expression in the retina ﬁeld
was only initiated. At e8.5, Six3 expression in the optic sulcus was
well established (Figs. 2A and B). In contrast, although Six3
expression was present in the presumptive pituitary/hypothalamic
axis and ventral forebrain of Lhx2 mutants, expression failed to be
initiated in the retina ﬁeld and optic sulcus (Figs. 2A and B).
Similarly, Pax6 and Rx expression was absent or reduced in the
anterior neural plate of Lhx2 mutants at e8.25 (Figs. 2C and D).
These results show that Lhx2 is required at the earliest stage of
retina speciﬁcation to initiate Six3, Rx and Pax6 expression within
the retina ﬁeld.
Lhx2 is required for Six6 expression in the optic vesicle
Although gene expression fails to be initiated at the neural plate
stage, Six3 expression was present (but reduced) at e9.0 in the optic
vesicle of Lhx2 mutants (Fig. 3B and E). Six3 expression was also
reduced in the prospective telencephalic vesicle of Lhx2 mutants (Fig.
3B). In contrast to Six3, expression of the Six3-related homeobox gene
Six6 is only initiated at 3–4 somites stage in the prospective pituitary/
hypothalamic axis, and later spreads to the presumptive ventral optic
stalk and optic vesicle at e9.0 (Jean et al., 1999). In Lhx2 mutants, we
observed normal Six6 expression pattern in the pituitary/hypothala-
mic axis at e9.0, but expression in the optic vesicle was not detected
(Figs. 3C and D). To further conﬁrm this observation, we performed
WISH using Rx as control for expression in the optic vesicle. Rx
expression was reduced but present in the optic vesicle of Lhx2−/−
embryos (Fig. 3A). To quantify these observations, we performed gene
expression analyses on forebrain extracts from e9.0 WT and Lhx2
mutant embryos by Real-time PCR. Because the optic vesicle of Lhx2
mutants is smaller even at this stage, we normalized for eye genes
expression using Rx as standard. Even after normalization, the
expression of Six3 and Six6 was still reduced by 75% and 85% in Lhx2
mutant forebrains, respectively (Fig. 3E). These results suggest that
Lhx2 is required to initiate Six6 and also possibly Six3 expression in
the optic vesicle.
Fig. 3. Lhx2 is required for Six6 expression in the optic vesicle. (A–D)Whole-mount in situ
hybridization shows that in e9.0 Lhx2−/− embryos, Rx (A) and Six3 (B) expression is present
but reduced in the optic vesicle (arrowheads). Six3 expression is also reduced in the
telencephalic vesicle of Lhx2−/− embryos (black arrowhead in panel B). In Lhx2−/− embryos,
Six6 expression is detected in the pituitary/hypothalamic axis (arrowhead in D) but not in
theoptic vesicle (C). Real-timePCR analysis of e9.0 forebrains revealed thatwhen compared
toWT littermates (n=4), Six3 and Six6 expression is highly reduced in Lhx2mutants (n=3),
evenwhen normalized to Rx expression level (E), which was set to 1. ⁎⁎Pb0.01.
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and trans-activate Six6 regulatory elements in vitro
Our results suggest that Lhx2 might bind to Six6 promoter regions
for expression in the developing retina. To test this, we characterized
the Six6 gene for putative Lhx2 DNA binding sites using the TRANS-
FACT algorithm. Several putative sites were identiﬁed in the 5′
promoter region and intron I of Six6 (Fig. 4B). Several putative DNA
binding sites were also identiﬁed for Pax6 (Fig. 4B). To test for
potential association of Lhx2 or Pax6 with the chromatin at these
regions in vivo, we performed chromatin immunoprecipitation
(ChIP) experiments on e12.5 mouse retinas (Duparc et al., 2007).
Based on the location of the putative DNA binding sites identiﬁed, we
scanned 18 chromatin domains each covering ∼300 base pairs of
genomic DNA. Lhx2 association with the chromatin was found in
genomic DNA regions corresponding to binding sites −3795, −1650
and −290 of Six6 (Fig. 4A). Pax6 association with the chromatin was
found in genomic DNA regions corresponding to binding sites −1650,
−290, +685 and +4180 of Six6. Common and robust association of
Lhx2 and Pax6 with the chromatin was found at sites −1650 and
−290. Control ChIP with an anti-IgG antibody or ampliﬁcation of the
β-globin promoter suggests that this association is speciﬁc (Fig. 4A-
inset, and data not shown).
Based on the bioinformatics and ChIP results, we hypothesized
that Lhx2 and Pax6 directly regulate Six6 transcription. To test this,
we performed Luciferase assay in 293T cells using 4 distinctgenomic DNA fragments covering the 5′ promoter region (position
−3964 to −75) and intron I (position +638 to +1703) of Six6 (Fig.
4C). We found that Lhx2 alone was not sufﬁcient to induce
signiﬁcant trans-activation of these DNA fragments. Pax6 alone
could trans-activate fragment 1 (position −3964 to −2465) and 3
(position −1284 to −75) just above the baseline level, which was
established at 3 (Fig. 4C). Notably, adding Lhx2 and Pax6 together
resulted in relatively strong trans-activation of fragments 1 and 2
(position −2480 to −1263) (Fig. 4C). Robust activation of fragment 2
using both factors correlated with co-association of Lhx2 and Pax6
with the chromatin at position −1650, which is contained within
fragment 2. We also tested if adding additional factors, such as Six3
and Otx2, could result in a more pronounced trans-activation of
Six6 regulatory elements (Zuber et al., 2003). Adding all factors
together did not enhanced Pax6 and Lhx2 activity on Six6 DNA
fragments. In contrast, it apparently interfered with the previously
observed activity on fragment 1 and 2 (Fig. 4C). These results
suggest that Lhx2 and Pax6 are associated with the chromatin at
the Six6 locus in vivo and can trans-activate Six6 regulatory
elements in vitro.
Lhx2 is required for Six6 expression in retinal progenitor/stem cells
We previously reported on the isolation and characterization of
NE retinal progenitors present in the mouse optic vesicle (Duparc
et al., 2007). These NE progenitors display all the characteristics of
retinal stem cells. We performed dissociated cultures of WT and
Lhx2-mutant optic vesicles at e9.0 in serum-free media to isolate
NE progenitors in a neurosphere assay (Duparc et al., 2007). Retinal
colonies from Lhx2 mutants were smaller and less abundant then
from WT littermates (Fig. 5A). Considering the reduce size of the
optic vesicle in Lhx2 mutants, we performed secondary colony
formation assay (self-renewal assay) from single spheres, allowing
normalization of the number of cells plated/well. Single spheres
were dissociated to single cell suspensions and 2000 cells/ml were
re-plated in the same media. Under these conditions, retinal
colonies were smaller and less abundant in the absence of Lhx2
(Fig. 5B and data not shown). To identify the underlying cellular
defect, we ﬁrst measured the mitotic index (PH3+/DAPI+ cells) in
WT and Lhx2−/− colonies. No signiﬁcant differences were found
between both genotypes (data not shown). The Ki67 antigen is
expressed at all phases of the cell cycle, but not in G0, and is used
as a marker for progenitors (Scholzen and Gerdes, 2000; Endl et al.,
2001). To analyze the cell cycle, spheres from both genotypes were
pulsed with Bromodeoxy-Uridine (BrdU) for 60 min and analyzed
on sections with antibodies against BrdU and Ki67 (Chenn and
Walsh, 2002; Klezovitch et al., 2004). BrdU incorporation assays
revealed a marked reduction in the number of BrdU+/DAPI+ cells
(Fig. 5C) and BrdU+/Ki67+ progenitor cells (Fig. 5D) in Lhx2−/−
colonies, suggesting that Lhx2−/− progenitors are partially arrested
at the G1 phase of the cell cycle. To further test this, we evaluated
the frequency of progenitors not having entered the S phase (i.e.
Ki67+/BdrU− cells) after chronic exposure to BrdU for 12 h. We
found that the frequency of unlabeled progenitors was signiﬁcantly
higher in Lhx2−/− colonies, again suggesting that Lhx2−/− progenitors
have a tendency to be arrested in G1 (Fig. 5E). We also measured
the frequency of apoptotic cells (activated caspase-3+/DAPI+ cells)
and found a signiﬁcant increase in the number of apoptotic cells in
Lhx2−/− retinal spheres (Fig. 5H).
To test if this system was relevant to study gene regulation, we
performed Real-time PCR analysis on WT and Lhx2−/− retinal
colonies. We found that Six3 and Six6 expression was reduced by
50% and 70% in Lhx2−/− colonies, respectively, thus similarly as in the
optic vesicle (Fig. 5F). Work performed in medaka (Oryzias latipes)
revealed that Six3 and Six6 proteins could promote cell cycle entry
and DNA replication in part by preventing the physical interaction of
Fig. 4. Lhx2 and Pax6 can bind to the chromatin at the Six6 loci in vivo and trans-activate Six6 regulatory elements in vitro. (A) ChIP scanning experiment at the Six6 loci on
e12.5 mouse retinas using anti-Lhx2, anti-Pax6 and anti-IgG antibodies (n=2). (A and B) Based on the location of several putative Lhx2 or Pax6 DNA binding sites covering
about 10 k base pairs of genomic DNA at the Six6 loci (B), PCR primers were designed to ampliﬁed 18 DNA fragments containing these sites. Quantitative analysis of the
input/ChIP ratio for each fragment reveals an enrichment of Lhx2 or Pax6 proteins on the chromatin at different regions of Six6 (A). ChIP enrichment was found signiﬁcant
when above the established arbitrary baseline level of 0.1. Control anti-IgG antibody and ampliﬁcation of a fragment of the β-globin (βMajor) promoter suggest that the
observed associations are speciﬁc (inset). (B) Physical map of the Six6 loci showing the 4 DNA fragments used in Luciferase assays. The white boxes correspond to exon I and
II of Six6. (C) Luciferase assays were performed in 293T cells using 4 genomic DNA fragments (n=3), and Luciferase activity was found signiﬁcant when above the established
arbitrary baseline level of 3.
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pre-replication complex (Del Bene et al., 2004). Six3 and Six6 may
also promote cell proliferation by repressing the transcription of
cyclin-dependent kinase inhibitors (Gestri et al., 2005; Li et al.,
2002). We compared cyclin-dependent kinase inhibitors (i.e. p21Cip1,
p27Kip1 and p57Kip2) expression in WT and Lhx2−/− retinal colonies,
micro-dissected e9.25 forebrains, and micro-dissected e9.0 optic
vesicles by Real-time PCR. We found that the expression of all 3
cyclin-dependent kinase inhibitors was increased in Lhx2−/− samples
in vitro and in vivo, with the most dramatic and consistent up-
regulation observed for p27Kip (Figs. 5F and G).
Over-expression of Six3 or Six6 in Medaka or Xenopus embryos
resulted in increased retinal progenitor cells proliferation and
ectopic retinal tissue formation (Bernier et al., 2000; Loosli et al.,
1999; Zuber et al., 1999). We rationalized that reduced expression of
Six6 and Six3 in Lhx2−/− retinal colonies may explain the proliferation
defect. To test this, we over-expressed Six6/GFP or GFP alone in WTand Lhx2−/− retinal colonies using lentiviruses. We observed that
cells infected with multiple Six6/GFP viral copies entered into
apoptosis within 48 h. Similar results were obtained with a Six3/GFP
lentivirus. However, using lower viral concentrations, we could
achieve conditions where the Six6/GFP virus was non-toxic. In
clonal dissociation assays, we found that Lhx2−/− retinal colonies
infected with the Six6/GFP virus were larger than those infected
with the GFP virus after 1 or 2 passages (GFP virus: 194±14 μm;
Six6/GFP virus: 230±24 μm, P=0.02). These results suggest that
restoring Six6 expression in Lhx2−/− retinal colonies can partially
rescue the growth defect, and reveal that Six3/Six6 gene-dosage is
extremely sensitive in this particular cellular context. Collectively,
our data show that Lhx2−/− retinal progenitor/stem cells generate
smaller colonies due to a proliferation defect and elevated apoptosis,
and suggest that the reduced proliferation phenotype is link to Six6
and Six3 down-regulation and increased cyclin-dependent kinase
inhibitors activity.
Fig. 5. Lhx2 is required for Six6 expression in retinal progenitor/stem cells. (A and B) Retinal spheres from Lhx2−/− embryos are smaller than WT littermates in primary cultures and
after serial passages of single spheres (Primary culture n=5, Secondary n=5, Tertiary n=3). (C and D) Immunoﬂuorescence on sections of retinal spheres exposed to BrdU for 90 min
revealed a marked reduction in BrdU incorporation in Lhx2−/− spheres (n=3) compared toWT (n=3). BrdU saturation experiment reveals that most Ki67+ Lhx2−/− progenitors have not
yet incorporate BrdU after12 h of BrdU exposition (E). Real-time PCR analysis of Six3 and Six6 (F), and p21Cip1, p27Kip1 and p57Kip2 expression levels in Lhx2−/− (n=5) and WT (n=5)
retinal spheres (F), Lhx2−/− (n=2) and WT (n=2) e9.0 optic vesicles (O.V.), and Lhx2−/− (n=2) and WT (n=2) e9.25 forebrains (n=2) (G). Immunohistochemistry on Lhx2−/− and WT
retinal sphere sections using an anti-activated caspase-3 antibody. Sections were mounted with DAPI to calculate the number of caspase-3+ cells over the total number of DAPI+ cells/
section (H). ⁎Pb0.05; ⁎⁎Pb0.01.
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Pax6 is not required for Six6 expression in the optic vesicle
(Jean et al., 1999). However, based on the ChIP and Luciferase assay
results, we hypothesized that Pax6 is required for Six6 expression
maintenance. We performed global gene expression analysis using
DNA micro-arrays to compare WT and Pax6-null retinal colonies
isolated from e9.5 optic vesicle (Duparc et al., 2007). These
experiments revealed that in Pax6−/− retinal colonies, Six6 is the
most down-regulated gene from the entire array (Fig. 6A). To
conﬁrm this, we performed gene expression analyses on individual
WT and Pax6−/− retinal spheres by RT-PCR. We found that in
contrast with Six3, Lhx2 and Otx2, which expression is apparentlynormal, expression of Six6 is undetectable in Pax6−/− samples (Fig.
6B). These results reveal that Pax6 is genetically required for Six6
expression in retinal progenitor/stem cells.
Lhx2 and Pax6 can synergistically activate Six6 expression in retinal
stem cells
To further explore the relationship between Lhx2, Pax6 and Six6
gene activation, we forced Lhx2 or Pax6 expression in cultured retinal
stem cells. Retinal colonies were dissociated to single cell suspensions
and electroporated with the Lhx2/GFP, Pax6/GFP or GFP-only DNA
constructs (Fig. 7). At the time of optimal GFP expression (i.e. 36 h
post-electroporation), cells were sorted by ﬂuorescence activated cell
Fig. 7. Lhx2 and Pax6 can synergistically activate Six6 expression in retinal progenitor/
stem cells. An experimental systemwas designed to electroporate plasmid DNA into cell
suspensions of dissociated retinal spheres (A). After 36 h of culture on matrigel, cells
were sorted for GFP expression by ﬂuorescence activated cell sorting (FACS) and RNA
was isolated from the GFP− and GFP+ cell populations (n=2). Quantiﬁcation of Lhx2,
Pax6, Six3 and Six6 expression in FACS puriﬁed cells using Real-time PCR. Hprt was used
as internal control for normalization of samples concentrations. Cells electroporated
with the GFP− only vector and sorted as GFP+ were used as standard reference (set at 1)
for the Pax6/GFP+ and Lhx2/GFP+ cell populations (B). Cells sorted as GFP−were used as
standard reference (set at 1) for the Pax6/GFP− and Lhx2/GFP− cell populations. These
experiments reveal that Six6 can be activated by Lhx2 alone, but not by Pax6 alone, or by
the combination of Lhx2 and Pax6 (numbers in bold).
Fig. 6. Pax6 is required for Six6 expression in retinal progenitor/stem cells. Comparative
DNA micro-array (Afﬁmetrix Chip) analysis of Pax6−/− and WT retinal spheres reveals
that Six6 is the most under-expressed gene in Pax6−/− cells (A). RT-PCR analysis on 4
individual retinal spheres from Pax6−/− and WT genotypes reveals that Six6 expression
is not detectable in Pax6−/− cells, in contrast to Six3, Lhx2 and Otx2. Gapdh was used as
the internal control (ctl) for normalization (B). ⁎Pb0.05; ⁎⁎Pb0.01.
548 N. Tétreault et al. / Developmental Biology 327 (2009) 541–550sorting for GFP expression and analyzed by Real-time PCR. When
compared together, GFP-positive and GFP-negative cells electropo-
rated with the control plasmid displayed near identical Six6 expres-
sion levels. However, GFP-positive cells electroporated with the Lhx2/
GFP construct had 9–10 fold higher Six6 expression levels and 2–3 fold
higher Six3 expression levels (Fig. 7). Pax6/GFP over-expression alone
had no detectable effect on Six3 or Six6 expression. To test the
possibility of cooperative activation, we electroporated a DNAmixture
containing Lhx2 and Pax6 constructs. Notably, Lhx2 and Pax6
constructs could induce together a ∼40 folds activation of Six6
transcription (Fig. 7). The impact on Six3 expression was comparable
to that of Lhx2/GFP over-expression alone. These results suggest that
Lhx2 and Pax6 can synergistically activate Six6 in retinal stem cells.
Discussion
Our data indicate that Lhx2 demarcates the presumptive retina
ﬁeld with Rx in the anterior neural plate, and that Lhx2 is required to
establish primitive retinal identity at this stage by either directly
inducing or allowing initiation of retinal genes expression. Although
Lhx2 mutants develop optic vesicles, similarly as Pax6-null mouse or
Six3-morphan medaka embryos, the impact of Lhx2 loss-of-function
on gene expression is unique. In both Pax6 and Six3mutants, initiation
of retinal gene expression (i.e. Rx, Pax6, Lhx2, Otx2 and Six3) is normal
at the neural plate and early optic vesicle stages, indicating that these
factors are not required for gene expression initiation (Bernier et al.,
2001; Carl et al., 2002). Similarly, Six6 expression is apparently normal
in the optic vesicle of Pax6-mutants (Jean et al., 1999). In contrast,
expression of Pax6, Rx, Six3 and Six6 is absent or delayed in the retina
ﬁeld and highly reduced in the optic vesicle of Lhx2 mutants. Six3
expression is also reduced in the telencephalic vesicles of Lhx2
mutants (see Fig. 3B). In this context, it is noteworthy that an inverse
genetic relationship has been proposed in the zebraﬁsh forebrain,
where Six3 apparently regulates Lhx2 expression and where Lhx2
over-expression could overcome Six3 knockdown (Ando et al. 2005).However, this genetic relationship is most unlikely in themouse visual
system. Hence, while Six3 is expressed earlier than Lhx2 in the
anterior neural plate (Oliver et al. 1995), its expression in the
presumptive retina ﬁeld occurs 6–12 h after that of Lhx2 and Rx.
At ﬁrst glance, our results suggest that Lhx2 may activate directly
Six3, Rx and Pax6 transcription in the retina ﬁeld, and thus operates at
the upper most position in the genetic hierarchy governing retina
formation. However, over-expression of Lhx2 alone in retinal stem
cells, while inducing Six6 expression, had little impact on Six3 or Pax6
expression. Furthermore, there is no report of eye-inducing activities
of Lhx2 in other model organisms. Thus, Lhx2 may not be sufﬁcient to
activate the expression of “upstream regulators” by its own in gain-of-
function experiments, but is clearly required for gene expression
initiation in the retina ﬁeld.
One possible alternative interpretation of these observations is
that Lhx2 may be involved in “potentiating” the expression of early
retinal determinant genes prior to the establishment of retinal
identity. Gene potentiation or priming as been proposed to be an
important mechanism for the developmental expression of lineage-
speciﬁc transcription factors prior to the establishment of deﬁnitive
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2007). Gene potentiation involves the maintenance of an accessible
chromatin conformation in multi-potent stem cells, counterbalancing
possible epigenetic silencing at speciﬁc loci (Bottardi et al., 2007;
Szutorisz et al., 2005). Whether Lhx2 has a function in modulating
chromatin organization or accessibility for other transcription factors
remains to be evaluated.
Once primitive retinal identity is established in the anterior
neural plate and optic sulcus, it is predicted that “master regulators
of eye development” such as Rx, Pax6, Six3, Lhx2 and Otx2 would
cooperate to establish deﬁnitive retinal identity by inducing high
expression levels of retinal determinant genes. The underlying
mechanisms to induce high gene expression levels could involve
synergistic activation and positive autoregulatory feedback loops.
We found here that the concerted action of Lhx2 and Pax6 results in
the synergistic activation of Six6 transcription. Notably, this
correlates with association of both Pax6 and Lhx2 with the
chromatin at the Six6 loci, sometime on the same chromatin region,
suggesting the possible formation of a yet uncharacterized mole-
cular complex. We also found that Lhx2 is required for Six6
expression initiation in the optic vesicle, and that Pax6 is required
for Six6 expression maintenance in cultured retinal stem cell
isolated from the optic vesicle. Interestingly, our results are in
accordance with studies performed in medaka and Xenopus
embryos. In Xenopus, combined over-expression of Pax6, Six3 and
Otx2 results in more robust ectopic eye induction than over-
expression of Pax6 alone, suggesting either synergistic activation
of retinal gene expression and/or more efﬁcient re-programming of
retinal competence in non-retinal tissues (Zuber et al., 2003). In
medaka, inactivation of Pax6 or Six3 is associated with normal
retinal gene expression at early optic vesicle stages, but gene
expression is lost later on, showing that Pax6 and Six3 are
individually required for gene expression maintenance (Carl et al.,
2002).
One of the most striking phenotype of Lhx2 mutants is the
reduced optic vesicle and forebrain size owing to reduced cell
proliferation (Porter et al. 1997). In Lhx2-null retinal progenitor/
stem cell cultures, we found that proliferation was highly reduced
and that progenitors were stalled at the G1 phase of the cell cycle at
higher frequencies than normal. Apoptosis was also elevated
compare to WT controls. The observed cell cycle phenotype
correlated with reduced Six3 and Six6 expression and increased
expression of cyclin-dependent kinase inhibitors in retinal progeni-
tor/stem colonies, e9.25 forebrains and e9.0 optic vesicles of Lhx2
mutants. These observations indirectly support the hypothesis that
Six3 and Six6 can repress cyclin-dependent kinase inhibitors
expression (Gestri et al., 2005; Li et al., 2002). They also highlight
the unanticipated opposite function of Pax6 in repressing retinal
progenitor/stem cells proliferation through activation of cyclin-
dependent kinase inhibitors expression (Duparc et al. 2007). The
complexity of the system is further revealed by the simultaneous
requirement for Pax6 in the maintenance of Six6 expression in
retinal colonies (this study). The biological signiﬁcance of the
apparent genetic antagonism between Lhx2 and Pax6 in optic
vesicle growth is unclear at the moment but could allow the
establishment of equilibrium in NE progenitors cell cycle kinetics.
In conclusion, our results suggest a model for early retinal
speciﬁcation where Lhx2 delineates the retina ﬁeld with Rx and
allows induction of eye gene expression in this domain, possibly by
“potentiating” the chromatin. Once primitive retinal identity is
established, Lhx2 cooperates with Pax6 for robust trans-activation of
downstream target genes such as Six6 in order to establish and
maintain deﬁnitive retinal identity. The herein proposed model likely
also involves Six3, Rx and Otx2 in a much more complex molecular
network, and could represent a common strategy to establish and
maintain cell type identity in different regions of the developing CNS.Acknowledgments
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